about
Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous DiabetesComparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.Histopathological retrospective study of canine renal disease in Korea, 2003~2008.Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment.Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers.Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization.Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives.Interactions between CXCR4 and CXCL12 promote cell migration and invasion of canine hemangiosarcoma.Retrospective study of melamine/cyanuric acid-induced renal failure in dogs in Korea between 2003 and 2004.Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.Establishment of a Patient-Derived Xenograft of Canine Enteropathy-Associated T-Cell Lymphoma, Large Cell Type.Effects of T lymphocytes, interleukin-1, and interleukin-6 on renal fibrosis in canine end-stage renal disease.CDX-2 and HER-3 expression in canine gastric and colorectal adenocarcinomasHistopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunctionCorrigendum to: "Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment" [Exp. Cell. Res. 2014 15 323(1) 155-64]Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma
P50
Q27316266-82C2A57B-0BF1-41A2-A751-1F8C9241A40DQ33568982-8448255C-DD09-473B-A82F-E680FCAD134DQ34389200-071DAC2A-1422-4A39-B165-CD65F0BBBBEBQ34633575-23C5AAC2-E9D6-4B6D-811D-5E703B118740Q35099091-60A6D76A-0915-4EED-B2BD-7F2CF7EC7ADEQ37628928-4835AE4A-8DA2-49B8-A35C-2E1F82C54D39Q37672882-A4AABC6F-2E03-4B50-B38A-851C34BFDE08Q38859309-7793241B-D9D9-4E76-9ED1-FC3154D2CAA4Q38963363-21C16D2A-2A08-416B-BB17-D3817D06BA1FQ44409594-05E7184A-D2A8-4069-95CC-1334D7ACC8D7Q44859548-F9CADCCD-9317-422A-B439-CA3954A455A6Q46100232-13B58139-7524-4F8A-B945-BEAEBEDB41F2Q47448276-A398436B-FFFF-44A9-AF0B-567CCB3D7960Q47909686-FBBE95EB-C881-4C90-845E-A9F87D27999AQ53814834-C78EA7F6-BE56-4145-B910-5C029407AD4DQ83215485-CA45A2DD-282A-432C-ADF3-4C7227BD7E1DQ83266159-7F1286B4-2230-4AEB-A6EE-0524EE03D92EQ90286952-E146CDDD-2DB7-4BB6-8116-A8B5E2D304A8Q90389588-2FE23820-0E47-41BD-82F8-A1B946C536FB
P50
description
researcher ORCID ID = 0000-0002-1645-0036
@en
name
Jong-Hyuk Kim
@ast
Jong-Hyuk Kim
@en
Jong-Hyuk Kim
@es
Jong-Hyuk Kim
@nl
type
label
Jong-Hyuk Kim
@ast
Jong-Hyuk Kim
@en
Jong-Hyuk Kim
@es
Jong-Hyuk Kim
@nl
prefLabel
Jong-Hyuk Kim
@ast
Jong-Hyuk Kim
@en
Jong-Hyuk Kim
@es
Jong-Hyuk Kim
@nl
P1153
35109326200
P31
P496
0000-0002-1645-0036